Search Results - thomas+anchordoquy

2 Results

Sort By:

Inhaled siRNA for age-related lung fibrosis

Idiopathic pulmonary fibrosis (IPF) is an age-related disease with an unrelenting and progressive clinical course. About 5 million people are affected with IPF globally and aged individuals in their 60s and 70s are the most at-risk population. Currently, therapeutic options are limited to two approved medications. Evidence by the research team supports...

Published: 11/30/2023 | Inventor(s): Sunad Rangarajan, Victor Thannickal, Thomas Anchordoquy

Disease Areas Regenerative Medicine

Category(s): Therapeutics

Using Milk Exosomes to Enhance Oral Drug Delivery

Problem: Many pharmaceuticals must be administered intravenously due to their poor oral bioavailability. In addition to issues associated with sterility and inconvenience, the cost of repeated infusion over a six-week course of therapy costs the healthcare system tens of billions of dollars per year and forces some patients to leave the comfort of their...

Published: 5/26/2023 | Inventor(s): Thomas Anchordoquy, Michael Graner, Jamie Betker, Brittany Angle

Disease Areas Oncology

Category(s): Therapeutics